Lipids and Cardiovascular Risk Management Perspective

 
 
  • CAC Scoring Can Help Guide Statin Therapy Dr Matthew Budoff, an investigator for the MESA trial, outlines the evidence in favor of calcium scoring for selecting patients who may and may not warrant statin therapy.
  • NAFLD and GUT: An Intriguing Association This case illustrates how metabolic factors and intestinal permeability can be the keys to reversing fatty liver disease.
  • The Impact of Age in Hypertension Care   Dr Henry Black sits down with Dr Joseph Izzo to talk about how old is old when it comes to controlling blood pressure, and other controversies in the evaluation and treatment of hypertension.
  • 2015's Unmissable Moments for Primary Care Some of the biggest problems faced by primary care providers in 2015 remain unresolved at year's end.
  • The World According to the General Practitioner   Dr Henry Black and internist Dr Nicholas Fiebach talk about blood pressure after JNC 8 and SPRINT, cholesterol screening , and other issues facing generalists.
  • Cardiology 2015: The Year in Review   Drs Harrington and Gibson give their annual review of the highs and lows in medicine with a focus on cardiology.
  • Mandrola's Top 10 Cardiology Stories 2015 In what is becoming an annual tradition, Dr John Mandrola reviews his top 10 stories of 2015 in the field of cardiovascular medicine.
  • EMPA-REG, PCSK9s, and the Future of Clinical Trials   Dr Michelle O'Donoghue interviews Dr Marc Sabatine about the EMPA-REG OUTCOME trial from AHA, the latest on PSCK9 inhibitors, and how clinical trials will be conducted in the future.
  • Vascular Disease Wake-up Call From AHA President Mark Creager   Drs Mark Creager and Ileana Piña discuss the importance of addressing vascular health among primary care physicians and their patients, and blood pressure management in light of the SPRINT trial.
  • CT Scans for Statin Eligibility: A Pandora's Box to Avoid   Drs Steve Nissen and Peter Libby discuss the 'incidentaloma' effect and other concerns about using calcium scoring to assess whether a patient should take a statin.
  • PCSK9 Inhibitors: How They Work and Who Should Get Them   Mayo Clinic cardiologists Jeffrey Geske, Scott Wright, and Stephen Kopecky discuss the brave new world of PCSK9 inhibitors.
  • Precision Medicine: More Understanding, Better Treatments   At Medscape's first Medicine 3.0 conference, Editor-in-Chief Eric Topol leads a panel discussion on how to make medicine more precise, stressing that it's not always about genomics.
  • American Heart Association (AHA) 2015 Scientific Sessions Read clinically focused news coverage of key developments from AHA 2015.
  • AHA AHA 2015 Scientific Sessions Previewed by John Mandrola Dr John Mandrola peruses the program for the upcoming American Heart Association Scientific Sessions in Orlando and outlines the studies he'll be looking out for.
  • A Brighter Future for Carotid Stenting?   Dr Frank Veith weighs in on the controversies surrounding carotid artery stenosis and its future role in the management of symptomatic and asymptomatic carotid stenosis.
  • How to Manage Muscle Pain in Patients on Statins Prof Bruckert explains the key steps in managing patients on statins who are experiencing muscle pain.
  • Asymptomatic Carotid Disease and the Fallacy of Preventive Surgery The "see lesion, stent lesion" approach to cardiology has been discredited. Dr Mandrola sees a parallel in the overuse of carotid endarterectomy and stenting in asymptomatic patients.
  • ESC Imagine Our World if We Taught It How to Eat Dr Walton-Shirley recounts a session on healthy eating, a fight against trans fats, the poor record of supplements in clinical trials and urges her fellow physicians to join her in the battle to get people to eat what's good for them.
  • ESC One-Liners From ESC 2015 Day 1 Dr Melissa Walton-Shirley zips through the take-home messages of 23 presentations.
  • New Cardio Drugs: Here's to Hopeful New Prescribing With new drugs on the market, Dr Melissa Walton-Shirley is optimistic but aware that extrapolating trial results to the broad population is still nothing more than a well-vetted leap of faith.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.